1. Arazi H, Damirchi A, Poulab E. [The effect of seven weeks of combined (aerobic-resistance) training on blood levels of serotonin and dopamine and physical fitness factors of addicted men to methamphetamine during rehabilitation]. Daneshvar Medicine. 2016;24(1):21-28. [Article in Persian] [ Link] 2. Kolluru GK, Glawe JD, Pardue S, Kasabali A, Alam S, Rajendran S, et al. Methamphetamine causes cardiovascular dysfunction via cystathionine gamma lyase and hydrogen sulfide depletion. Redox Biol. 2022 Nov;57:102480. doi: 10.1016/j.redox.2022.102480. [ DOI] [ PubMed] 3. Akhgari M, Mobaraki H, Etemadi-Aleagha A. Histopathological study of cardiac lesions in methamphetamine poisoning-related deaths. Daru. 2017 Feb;25(1):5. doi: 10.1186/s40199-017-0170-4. [ DOI] [ PubMed] 4. Kevil CG, Goeders NE, Woolard MD, Bhuiyan MS, Dominic P, Kolluru GK, et al. Methamphetamine Use and Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):1739-46. doi: 10.1161/ATVBAHA.119.312461. [ DOI] [ PubMed] 5. Berridge KC. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl). 2007 Apr;191(3):391-431. doi: 10.1007/s00213-006-0578-x. [ DOI] [ PubMed] 6. Cavallotti C, Mancone M, Bruzzone P, Sabbatini M, Mignini F. Dopamine receptor subtypes in the native human heart. Heart Vessels. 2010 Sep;25(5):432-37. doi: 10.1007/s00380-009-1224-4. [ DOI] [ PubMed] 7. Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol. 2007;47:681-98. doi: 10.1146/annurev.pharmtox.47.120505.105140. [ DOI] [ PubMed] 8. Booz GW. PARP inhibitors and heart failure--translational medicine caught in the act. Congest Heart Fail. 2007 Mar-Apr;13(2):105-12. doi: 10.1111/j.1527-5299.2007.06595.x. [ DOI] [ PubMed] 9. Piepoli MF, Davos C, Francis DP, Coats AJ. Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ. 2004 Jan 24;328(7433):189. doi: 10.1136/bmj.37938.645220.EE. [ DOI] [ PubMed] 10. Arazi H, Dadvand SS, Suzuki K. Effects of exercise training on depression and anxiety with changing neurotransmitters in methamphetamine long term abusers: A narrative review. Biomedical Human Kinetics. 2022; 14(1): 117-26. doi: 10.2478/bhk-2022-0015. [ Link] [ DOI] 11. Derosa G, Maffioli P, Cicero AF. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther. 2012 Aug;12(8):1113-24. doi: 10.1517/14712598.2012.704014. [ DOI] [ PubMed] 12. Kawano M, Takagi R, Kaneko A, Matsushita S. Berberine is a dopamine D1- and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses. J Neuroimmunol. 2015 Dec;289:43-55. doi: 10.1016/j.jneuroim.2015.10.001. [ DOI] [ PubMed] 13. Hedges DM, Obray JD, Yorgason JT, Jang EY, Weerasekara VK, Uys JD, et al. Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway. Neuropsychopharmacology. 2018 May;43(6):1405-14. doi: 10.1038/npp.2017.291. [ DOI] [ PubMed] 14. Shahrabadi H, Haghighi AH, Askari R, Asadi-Shekaari M. [The Effect of Eight Weeks of High-Intensity Interval Training on Cardiac PARP-1 Gene Expression in Methamphetamine-Dependent Male Rats]. J North Khorasan Univ Med Sci. 2022;14(1):45-51. doi: 10.52547/nkums.14.1.45. [Article in Persian] [ Link] [ DOI] 15. Bo B, Zhou Y, Zheng Q, Wang G, Zhou K, Wei J. The Molecular Mechanisms Associated with Aerobic Exercise-Induced Cardiac Regeneration. Biomolecules. 2020 Dec;11(1):19. doi: 10.3390/biom11010019. [ DOI] [ PubMed] 16. Sadighi A, Abdi A, Azarbayjani MA, Barari A. [Effect of Aerobic Training and Berberine Chloride Supplementation on Oxidative Stress Indices in the Heart Tissue of Streptozotocin-Induced Diabetic Rats]. J. Ilam Uni. Med. Sci. 2020;28(4):54-65. doi: 10.29252/sjimu.28.4.54. [Article in Persian] [ Link] [ DOI] 17. Tokunaga I, Kubo S, Ishigami A, Gotohda T, Kitamura O. Changes in renal function and oxidative damage in methamphetamine-treated rat. Leg Med (Tokyo). 2006 Jan;8(1):16-21. doi: 10.1016/j.legalmed.2005.07.003. [ DOI] [ PubMed] 18. Rezaeian L, Khaksari M, Rafaiee R, Kalalian Moghaddam H. Neuroprotective Effects of Berberine Hydrochloride on Methamphetamine-induced Cognitive Dysfunction: Immunohistochemical and Behavioral Studies in Rats. Basic Clin Neurosci. 2022 Jul-Aug;13(4):443-53. doi: 10.32598/bcn.2021.1444.2. [ DOI] [ PubMed] 19. Sajadi A, Amiri I, Gharebaghi A, Komaki A, Asadbegi M, Shahidi S, et al. Treadmill exercise alters ecstasy- induced long- term potentiation disruption in the hippocampus of male rats. Metab Brain Dis. 2017 Oct;32(5):1603-1607. doi: 10.1007/s11011-017-0114-1. [ DOI] [ PubMed] 20. Scobie KN, Damez-Werno D, Sun H, Shao N, Gancarz A, Panganiban CH, et al. Essential role of poly(ADP-ribosyl)ation in cocaine action. Proc Natl Acad Sci U S A. 2014 Feb;111(5):2005-10. doi: 10.1073/pnas.1319703111. [ DOI] [ PubMed] 21. Vallerini GP, Cheng YH, Chase KA, Sharma RP, Kusumo H, Khakhkhar S, et al. Modulation of Poly ADP Ribose Polymerase (PARP) Levels and Activity by Alcohol Binge-Like Drinking in Male Mice. Neuroscience. 2020 Nov;448:1-13. doi: 10.1016/j.neuroscience.2020.09.010. [ DOI] [ PubMed] 22. Pillai JB, Russell HM, Raman J, Jeevanandam V, Gupta MP. Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure. Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H486-96. doi: 10.1152/ajpheart.00437.2004. [ DOI] [ PubMed] 23. Ascensão A, Ferreira R, Magalhães J. Exercise-induced cardioprotection--biochemical, morphological and functional evidence in whole tissue and isolated mitochondria. Int J Cardiol. 2007 Apr;117(1):16-30. doi: 10.1016/j.ijcard.2006.04.076. [ DOI] [ PubMed] 24. Ke Y, Wang C, Zhang J, Zhong X, Wang R, Zeng X, et al. The Role of PARPs in Inflammation-and Metabolic-Related Diseases: Molecular Mechanisms and Beyond. Cells. 2019 Sep;8(9):1047. doi: 10.3390/cells8091047. [ DOI] [ PubMed] 25. Ethier C, Tardif M, Arul L, Poirier GG. PARP-1 modulation of mTOR signaling in response to a DNA alkylating agent. PLoS One. 2012;7(10):e47978. doi: 10.1371/journal.pone.0047978. [ DOI] [ PubMed] 26. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology. 2009;56 Suppl 1(Suppl 1):3-8. doi: 10.1016/j.neuropharm.2008.05.022. [ DOI] [ PubMed] 27. Roberts BM, Seymour PA, Schmidt CJ, Williams GV, Castner SA. Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists. Psychopharmacology (Berl). 2010 Jun;210(3):407-18. doi: 10.1007/s00213-010-1840-9. [ DOI] [ PubMed] 28. Miyamoto Y, Iida A, Sato K, Muramatsu S, Nitta A. Knockdown of dopamine D₂ receptors in the nucleus accumbens core suppresses methamphetamine-induced behaviors and signal transduction in mice. Int J Neuropsychopharmacol. 2014 Oct;18(4):pyu038. doi: 10.1093/ijnp/pyu038. [ DOI] [ PubMed] 29. Nosrati Z. [The effect of endurance activity associated with berberine hydrochloride supplementation on histopathological changes of heart tissue and aerobic capacity in rats receiving methamphetamine]. MA Thesis. Shahrood Branch, Islamic Azad University, Iran. 2022. [Persian]
|
